WallStreetZenWallStreetZen
Analyst Ranking
Top 3%
#94 out of 4485 analysts
Average Return
+36.13%
Win Rate
37%49 out of 131
Risk vs Reward
Poor
Good

Keay Nakae's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Ocugen IncOCGN
+5,554.71%$0.22$12.61
2020-06-03 -
2021-02-09
Strong Buy
Femasys IncFEMY
+416.28%$0.43$2.22
2023-08-11 -
2024-03-04
Strong Buy
Femasys IncFEMY
+351.22%$0.49$2.22
2023-07-03 -
2024-03-04
Strong Buy
Silence Therapeutics PLCSLN
+285.46%$6.81$26.25
2023-08-17 -
2024-03-04
Strong Buy
Silence Therapeutics PLCSLN
+191.99%$8.99$26.25
2023-03-16 -
2024-03-04
Strong Buy

Keay Nakae's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Arbutus Biopharma CorpABUS
6Strong Buy$4.00+47.60%Reiterates
4 days ago
Avidity Biosciences IncRNA
6Strong Buy$23.00+21.95%Reiterates
5 days ago
Alnylam Pharmaceuticals IncALNY
5Strong Buy$225.00+49.96%Maintains
18 days ago
Sonnet Biotherapeutics Holdings IncSONN
8Strong Buy$30.00+1,487.30%Maintains
19 days ago
Proqr Therapeutics NvPRQR
7Strong Buy$2.00+3.09%Upgrades
4 months ago
Silence Therapeutics PLCSLN
4Strong Buy$26.00-0.95%Reiterates
7 months ago
Gain Therapeutics IncGANX
3Strong Buy$6.00+27.12%Reiterates
7 months ago
Synlogic IncSYBX
4Strong Buy$90.00+4,872.38%Reiterates
7 months ago
Orchestra Biomed Holdings IncOBIO
4Strong Buy$20.00+182.09%Reiterates
7 months ago
Femasys IncFEMY
6Strong Buy$10.00+350.45%Reiterates
7 months ago
Better Therapeutics IncBTTX
6Strong Buy$9.00+4,539.18%Reiterates
7 months ago
Coya Therapeutics IncCOYA
8Strong Buy$11.00+10.00%Reiterates
7 months ago
Arrowhead Pharmaceuticals IncARWR
7Strong Buy$60.00+70.89%Reiterates
7 months ago
Mesoblast LtdMESO
7Strong Sell$6.00+192.68%Maintains
7 months ago
Omega Therapeutics IncOMGA
3Strong Buy$12.00+189.86%Reiterates
7 months ago
Dyne Therapeutics IncDYN
3Strong Buy$20.00-27.82%Reiterates
7 months ago
Sab Biotherapeutics IncSABS
6Strong Buy$30.00+589.66%Reiterates
9 months ago
Seres Therapeutics IncMCRB
3Strong Buy$10.00+777.19%Maintains
10 months ago
Pear Therapeutics IncPEARQ
5Hold$8.00+27,486.21%Downgrades
a year ago
Evelo Biosciences IncEVLO
4Hold$50.00N/ADowngrades
a year ago
Biomx IncPHGE
4Strong Buy$2.00N/AMaintains
a year ago
Emergent Biosolutions IncEBS
8Strong Buy$55.00N/AMaintains
a year ago
Axcella Health IncAXLA
4Strong Buy$125.00N/AMaintains
a year ago
Neubase Therapeutics IncNBSE
5HoldN/AN/ADowngrades
a year ago
Exicure IncXCUR
5Hold$2.00N/AMaintains
2 years ago
4d Pharma PLCLBPS
1HoldN/AN/ADowngrades
2 years ago
Kaleido Biosciences IncKLDO
3Hold$1.70N/ADowngrades
2 years ago
Dicerna Pharmaceuticals IncDRNA
3Hold$38.25N/ADowngrades
2 years ago
Forte Biosciences IncFBRX
2Hold$3.50N/AUpgrades
2 years ago
Ocugen IncOCGN
2Hold$13.00N/ADowngrades
3 years ago
Oncocyte CorpOCX
2Hold$40.00N/ADowngrades
4 years ago
Lisata Therapeutics IncLSTA
1Strong Buy$7.00N/AMaintains
6 years ago
Carecloud IncCCLD
1Strong Buy$2.75N/AMaintains
6 years ago
Biocept IncBIOCQ
1Strong Buy$22,500.00N/AInitiates Coverage On
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.